“Our entire organization is focused on our mission to bring these high-impact, innovative, device-based therapies to market.” - David Hochman
Find our Q2 2025 financial results and business updates here: https://t.co/UeZg5lFZFx
#OrchestratingInnovation#CardioTwitter
🌟 Dr. Vivek Reddy joins us as Executive Chairman of the BACKBEAT study & Chair of our Bioelectronic Therapies Scientific Advisory Board!
https://t.co/2PIQUnaV20
#Cardiology#Leadership
Exciting news: Chris Cleary, former SVP of Corporate Development at @Medtronic, joins our board!
Read how his leadership will help us drive innovation in cardiology: https://t.co/CM59P5OZe6
#Cardiology#Leadership
In 2024, we launched the BACKBEAT pivotal study, shared data at conferences worldwide, hosted our first R&D day, and added 11 new team members!
The future is bright for our #Cardiology work! ✨
#CardioTwitter
The holidays can pose some challenges for your heart health with factors such as stress, diet, disrupted sleep and exercise changes. By preparing in advance, you can better enjoy your time with family and friends. Review our checklist to learn more.
#CardioTwitter
Since 1892, the @nyphil orchestra has set the bar for #innovation & creativity—the same values we at Orchestra BioMed embrace in every step. Happy anniversary!
Learn more about our approach: https://t.co/osoPXJYHfx
#CardioTwitter
#GivingTuesday is all about doing one good thing, whether donating your time or raising awareness on a cause such as cardiovascular disease ❤️
To help build a better world, visit https://t.co/2ylaR0Os7I
Atherosclerotic artery disease is a leading cause of cardiovascular problems. We are researching treatments to help patients manage this condition effectively.
Learn more about our work with partners to bring these solutions to life: https://t.co/osEJxgabAP
#cardiology
Collaboration is at the heart of what we do.
We’re proud to work with our incredible partners to develop cutting-edge treatments that clinicians can trust. Together, we're making a difference in #cardiology and beyond.
https://t.co/SLgH6mWapL
Yesterday, we reported second-quarter financial results and provided a business update. Read our press release for more information: https://t.co/8t46CoR0zV
#news
In honor of #MensHealthMonth we hope to shine a light on a critical issue in men’s health. OBIO is dedicated to helping hypertensive pacemaker patients manage #HighBloodPressure effectively not only in June but year-round.
David Hochman and Matt Taylor hosted a fireside chat at the @Jefferies conference earlier this month. Watch the recording here: https://t.co/3xgp19u0nj
For disclaimers, please visit: https://t.co/6uVSAsTIpq
#JefferiesHealthcare
Thank you to everyone who joined us for our R&D Day!
Our efforts are paving the way for groundbreaking treatments for hypertensive pacemaker patients. We’re excited for the future of cardiovascular health & the innovations ahead.
Learn more: https://t.co/RJ5HvNUExK
Next week at the @Jefferies conference, our CEO David Hochman is participating in a fireside chat with Matt Taylor. We’d love to see you there!
https://t.co/7idoKbVCif
#JefferiesHealthcare
Today, we celebrate #WorldHypertensionDay, a day highlighting the importance of managing blood pressure and bringing awareness to the 1 billion people living with #HighBloodPressure.
We are proud to be innovating to help improve clinical outcomes for high-risk pacemaker patients.